JW (Cayman) Therapeutics Co. Ltd
JWCTF
Price:
$0.2375
Market Cap:
$577.99M
JW (Cayman) Therapeutics Co. Ltd is a biopharmaceutical entity currently in the clinical development phase, dedicated to the discovery, manufacturing, and commercialization of advanced cell-based immunotherapeutic solutions. Its core mission is to combat both hematological cancers (blood cancers) and various solid tumors. The company's innovative treatments encompass cell-derived immunotherapies, particularly Chimeric Antigen Receptor T-cell (CAR-T) therapies, which leverage a patient's own immune cells to target and eliminate cancerous cells. Leading its clinical efforts is Carteyva (relmacabtagene autoleucel), an anti-CD19 CAR-T therapeutic agent aimed at various forms of blood cancer. Bey...[Read more]
Industry
Biotechnology
IPO Date
2021-07-15
Stock Exchange
OTC
Ticker
JWCTF
PE Ratio
[-1.19]
ROE
[-75.15%]
Current Ratio
[1.45]
Dividend Yield
[0%]
Enterprise Value
[337.38M]
Dividend History
The ROE as of June 2026 (TTM) for JW (Cayman) Therapeutics Co. Ltd (JWCTF) is -75.15%
According to JW (Cayman) Therapeutics Co. Ltd’s latest financial reports and current stock price. The company's current ROE is -75.15%. This represents a change of 137.64% compared to the average of -31.62% of the last 4 quarters.
JW (Cayman) Therapeutics Co. Ltd (JWCTF) Historical ROE (quarterly & annually)
How has JWCTF ROE performed in the past?
The mean historical ROE of JW (Cayman) Therapeutics Co. Ltd over the last ten years is -18.59%. The current -75.15% ROE has changed 304.28% with respect to the historical average. Over the past ten years (40 quarters), JWCTF's ROE was at its highest in in the June 2020 quarter at 64.14%. The ROE was at its lowest in in the December 2025 quarter at -50.89%.
Average
-18.59%
Median
-40.78%
Minimum
-97.20%
Maximum
87.04%
JW (Cayman) Therapeutics Co. Ltd (JWCTF) ROE by Quarter and Year
Discovering the peaks and valleys of JW (Cayman) Therapeutics Co. Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 92.41%
Maximum Annual ROE = 87.04%
Minimum Annual Increase = -172.19%
Minimum Annual ROE = -97.20%
| Year | ROE | Change |
|---|---|---|
| 2025 | -97.20% | 92.41% |
| 2024 | -50.52% | 10.76% |
| 2023 | -45.61% | 26.90% |
| 2022 | -35.94% | 42.82% |
| 2021 | -25.17% | -48.12% |
| 2020 | -48.51% | -172.19% |
| 2019 | 67.20% | -22.80% |
JW (Cayman) Therapeutics Co. Ltd (JWCTF) Average ROE
How has JWCTF ROE performed in the past?
The current ROE of JW (Cayman) Therapeutics Co. Ltd (JWCTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-64.44%
5-year avg
-50.89%
10-year avg
-18.59%
JW (Cayman) Therapeutics Co. Ltd (JWCTF) ROE vs. Peers
How is JWCTF’s ROE compared to its peers?
JW (Cayman) Therapeutics Co. Ltd’s ROE is greater than Molecular Partners AG (-66.19%), less than Santhera Pharmaceuticals Holding AG (684.83%), greater than Brii Biosciences Limited (-8.92%), greater than Genfit S.A. (-596.44%), less than Innate Pharma S.A. (593.93%), greater than NervGen Pharma Corp. (-17536.81%), greater than NDT Pharmaceuticals Inc. (-33.16%), greater than Botanix Pharmaceuticals Limited (-131.13%), less than Scancell Holdings plc (90.29%), greater than YourWay Cannabis Brands Inc. (-117.87%),
| Company | ROE | Market cap |
|---|---|---|
| -66.19% | $181.93M | |
| 684.83% | $344.83M | |
| -8.92% | $107.82M | |
| -596.44% | $499.80M | |
| 593.93% | $154.94M | |
| -17536.81% | $312.89M | |
| -33.16% | $84.22M | |
| -131.13% | $48.06M | |
| 90.29% | $286.61M | |
| -117.87% | $2.88K |
Build a custom stock screener for JW (Cayman) Therapeutics Co. Ltd (JWCTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like JW (Cayman) Therapeutics Co. Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
JW (Cayman) Therapeutics Co. Ltd (JWCTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like JW (Cayman) Therapeutics Co. Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is JW (Cayman) Therapeutics Co. Ltd's ROE?
How is the ROE calculated for JW (Cayman) Therapeutics Co. Ltd (JWCTF)?
What is the highest ROE for JW (Cayman) Therapeutics Co. Ltd (JWCTF)?
What is the 3-year average ROE for JW (Cayman) Therapeutics Co. Ltd (JWCTF)?
What is the 5-year average ROE for JW (Cayman) Therapeutics Co. Ltd (JWCTF)?
How does the current ROE for JW (Cayman) Therapeutics Co. Ltd (JWCTF) compare to its historical average?